Our Website Uses Cookies
We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.
For more information, please contact us or consult our Privacy Notice.
Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
Martin Beeler is resident in our New York office. His practice focuses on bankruptcy, restructuring, and debtor-creditor rights, and includes both transactional and bankruptcy litigation matters. His clients have included debtors, creditors, secured and unsecured lenders, debtor-in-possession lenders, creditors’ committees, equity holders, chapter 11 trustees, and indenture trustees on defaulted securities. Mr. Beeler also practices in the areas of mergers & acquisitions and secured finance.
- Wilmington Trust Company as indenture trustee for $48 billion of bonds issued by Lehman Brothers Holding Inc. and as co-chair of the official creditors' committee in the Lehman Brothers Chapter 11 case.
- Calyon New York Branch as syndicate agent for senior secured and DIP lenders in the chapter 11 case of Southaven Power, LLC, and in connection with other troubled project financings.
- Isuzu Motors Company in connection with its North American operations.
- Wilmington Trust Company, as indenture trustee, as a member of the official committee of unsecured creditors in the FiberMark chapter 11 case.
- US policyholders opposing solvent schemes of arrangement proposed in the UK by insurers BAIC and WFUM pools.
- A major retailer, as a vendor endorsee under insurance policies, in contesting the proposed “buy-back” and settlement of the policies by a chapter 11 debtor/primary insured.
- A major oil & gas company in connection with the spinoff of its chemicals subsidiary.
- Swiss Post/Mail Source AG in its acquisition of Forrest Solutions.
- A minority investor in the recapitalization of WRG Media, Inc., and the disposition of related assets.
- BNY Capital Partners and The 1818 Mezzanine Fund in the restructuring of Caliber Holdings Corp.
- A major sports league in connection with the third-party acquisition of a licensee of the league’s intellectual property, and in connection with various team financings.
Pro Bono
- Representation, through Volunteer Lawyers for the Arts, of an artist in the bankruptcy of a gallery owner.
- Advised nonprofit organization committed to the furtherance of Finnish music in the USA regarding governance and exempt-organization matters.
- Represented amici curiae in National Abortion Federation v. Alberto Gonzales, a challenge to the Partial Birth Abortion Ban Act of 2003, on appeal in the United States Court of Appeals for the Second Circuit.
March 20, 2020, Covington Alert
The full ramifications of the COVID-19 pandemic are uncertain, but we should expect that significant economic dislocation will be felt not only by industries already suffering from financial distress and seeking bankruptcy relief (retail, healthcare, small biotech, pharma companies, and energy) but many other industries, including manufacturers, carriers, ...
Covington Represents Dana-Farber in Royalty Monetization
August 5, 2016
NEW YORK—Covington advised Dana-Farber Cancer Institute in its monetization of a portion of its interest in royalties related to its Programmed Death Ligand-1 (PD-L1) intellectual property. PD-L1 inhibitors are immuno-oncology drugs used for the treatment of various types of metastatic cancer. CPPIB Credit Europe S.à r.l., a wholly owned subsidiary of Canada ...
Covington Represents MRCT in Royalty Monetization Deal
July 15, 2016
NEW YORK—Covington advised Medical Research Council Technology, a UK-based independent life science medical research charity, in its sale of a portion of the royalty stream associated with its cancer drug Keytruda® for $150 million (£115.6 million). Keytruda® (pembrolizumab), is a new generation treatment which stimulates the body’s immune system to fight ...
Covington Announces Ten New Counsel
April 10, 2015
WASHINGTON, DC, April 10, 2015 — Covington is pleased to announce the promotion of three lawyers to of counsel and seven lawyers to special counsel, effective April 1, 2015. The new of counsel are as follows: John Balzano (New York) represents companies and industry associations on U.S. and China regulatory and policy matters related to food, drugs, and ...
Covington Lawyers Recognized by NY Super Lawyers
September 24, 2012
NEW YORK, September 24, 2012 — New York Super Lawyers selected 27 Covington & Burling lawyers for its 2012 list of top legal talent. Super Lawyers selects only five percent of the total lawyers in the state based upon peer review and the publication’s independent research. Nineteen Covington lawyers were named New York Super Lawyers: Jack Bodner, Mergers & ...
May 30, 2012, Covington E-Alert
July 5, 2011
NEW YORK, July 5, 2011 — Covington & Burling LLP represented Microsoft Corp. in the $4.5 billion winning bid in the auction of Nortel Networks Corporation’s 6000 patents and patent applications. A consortium of Microsoft and several other technology companies will share Nortel’s 4G wireless, data networking, optical, voice, Internet, service provider, ...
Covington Advises Resource Capital Corporation on the Acquisition of Churchill Pacific Asset Management LLC
March 3, 2011
NEW YORK, March 3, 2011 — Resource Capital Corporation (RSO) has announced that it has completed its purchase of 100 percent of the ownership interests in Churchill Pacific Asset Management LLC (CPAM) from Churchill Financial Holdings LLC. CPAM is the collateral manager to five Collateralized Loan Obligations (CLOs) totaling approximately $1.9 billion in assets. ...
March 23, 2010, Covington Advisory
December 2002, The Bankruptcy Strategist, Vol. XX, No. 2
- New York Super Lawyers, Bankruptcy & Creditor/Debtor Rights (2013)
COVID-19: Legal and Business Toolkit
We are helping clients around the world navigate this evolving, complex situation.